Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Betagan Unit Dose 0.5% eye drops 0.4ml unit dose
1106000T0BBABAB
|
Betagan | Levobunolol hydrochloride | Eye | 926 |
|
Virgan 0.15% eye gel
1103030W0BBAAAA
|
Virgan | Ganciclovir | Eye | 923 |
|
Timoptol 0.25% eye drops
1106000Z0BBAAAA
|
Timoptol | Timolol | Eye | 916 |
|
Minims saline 0.9% eye drops 0.5ml unit dose
1108010K0BBAAAY
|
Minims sodium chloride | Sodium chloride | Eye | 900 |
|
Levofloxacin 5mg/ml eye dps 0.3ml ud preservative free
1103010AGAAACAC
|
Levofloxacin (Eye) | Levofloxacin | Eye | 876 |
|
Artelac Single Dose Unit 0.32% eye drops 0.5ml unit dose
1108010F0BIABBS
|
Artelac | Hypromellose | Eye | 873 |
|
Opticrom Hayfever 2% eye drops
1104020T0BBAFAA
|
Opticrom | Sodium cromoglicate | Eye | 867 |
|
Hyetellose 0.44% eye drops 0.5ml unit dose preservative free
1108010H0AAAAAA
|
Hyetellose | Hyetellose | Eye | 864 |
|
Pilocarpine hydrochloride 4% eye drops
1106000X0AAAEAE
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | 864 |
|
Vizidor Duo 20mg/ml / 5mg/ml eye drops
1106000ABBEAAAC
|
Vizidor Duo | Dorzolamide and timolol | Eye | 841 |
|
Eysano 2.5mg/ml eye drops
1106000Z0BIAAAT
|
Eysano | Timolol | Eye | 839 |
|
Blephagel 0.36% eye gel preservative free
1108030AABBABAB
|
Blephagel | Carbomer | Eye | 837 |
|
Eysano 5mg/ml eye drops
1106000Z0BIABAU
|
Eysano | Timolol | Eye | 804 |
|
Latanoprost 50microg/ml / Netarsudil 200microg/ml eye dps
1106000ANAAAAAA
|
Latanoprost/Netarsudil | Latanoprost and Netarsudil | Eye | 782 |
|
Eythalm 1mg/ml eye drops
1104010I0BIAAAU
|
Eythalm | Dexamethasone | Eye | 775 |
|
Betaxolol 0.25% eye drops
1106000I0AAABAB
|
Betaxolol | Betaxolol | Eye | 743 |
|
Minims pilocarpine nitrate 2% eye drops 0.5ml unit dose
1106000Y0BBACAB
|
Minims pilocarpine nitrate | Pilocarpine nitrate | Eye | 742 |
|
Zimed 0.3mg/ml eye drops preservative free
1106000AFBEAAAD
|
Zimed | Bimatoprost | Eye | 733 |
|
Systane lid wipes
110801000BLASAB
|
Proprietary compound preparation BNF 1108010 | Other eye tear/lubricant/astringent preparations | Eye | 728 |
|
Verkazia 1mg/ml eye drops emulsion 0.3ml unit dose
1104020AEBCAAAA
|
Verkazia | Ciclosporin (Eye Anti Inflammatory) | Eye | 723 |
|
Saflutan 15micrograms/ml eye drops
1106000AKBBABAB
|
Saflutan | Tafluprost | Eye | 713 |
|
Bimi 0.3mg/ml eye drops
1106000AFBGAAAD
|
Bimi | Bimatoprost | Eye | 686 |
|
Exocin 0.3% eye drops
1103010Y0BBAAAA
|
Exocin | Ofloxacin | Eye | 669 |
|
Cyclopentolate 0.5% eye drops
1105000E0AAABAB
|
Cyclopentolate hydrochloride | Cyclopentolate hydrochloride | Eye | 613 |
|
Ciloxan 0.3% eye drops
1103010B0BBAAAA
|
Ciloxan | Ciprofloxacin | Eye | 563 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.